ES2064780T3 - Composiciones con penetracion mejorada. - Google Patents

Composiciones con penetracion mejorada.

Info

Publication number
ES2064780T3
ES2064780T3 ES91102354T ES91102354T ES2064780T3 ES 2064780 T3 ES2064780 T3 ES 2064780T3 ES 91102354 T ES91102354 T ES 91102354T ES 91102354 T ES91102354 T ES 91102354T ES 2064780 T3 ES2064780 T3 ES 2064780T3
Authority
ES
Spain
Prior art keywords
compositions
active
solvent
component
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91102354T
Other languages
English (en)
Inventor
Majid Mahjour
Bernadette Mauser
Edwards Eonchao Linn
Zahra Rashidbaigi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32512850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2064780(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ZA91624A external-priority patent/ZA91624B/xx
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2064780T3 publication Critical patent/ES2064780T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Laminated Bodies (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Physical Water Treatments (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)

Abstract

LA INVENCION CONSISTE EN UNA LAMINA COMPUESTA DE DOS CAPAS PARA LA ADMINISTRACION TRANSMEMBRANAL DE UN MEDICAMENTO ACTIVO COMPUESTO DE A) UNA CAPA I COMPUESTA DE UN COMPONENTE A QUE CONSISTE EN UN SOLVENTE Y UN MEDICAMENTO ACTIVO INCORPORADO EN UN ELASTOMERO PARCIALMENTE CURADO, B) UNA CAPA II LAMINADA SOBRE LA CAPA I COMPUESTA DE UN COMPONENTE B QUE CONSISTE EN UN SOLVENTE Y MEDICAMENTO ACTIVO V. GR. THA (TACRINA) INCORPORADO EN UNA TABLETA MACROPOROSA CON UN TAMAÑO DE PORO DE 10 A 100 (MU)M.
ES91102354T 1988-03-08 1991-02-19 Composiciones con penetracion mejorada. Expired - Lifetime ES2064780T3 (es)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US16532288A 1988-03-08 1988-03-08
NZ236921A NZ236921A (en) 1988-03-08 1991-01-28 Laminate for transmembranal administration of a drug
ZA91624A ZA91624B (en) 1991-01-28 1991-01-28 Delivery device for compositions with enhanced penetration and process for preparing same
IE30591A IE64308B1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
AU70061/91A AU634015B2 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
CA002035143A CA2035143A1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
FI910455A FI910455L (fi) 1988-03-08 1991-01-30 Komposition med foerbaettrad penetration.
KR1019910001750A KR100191456B1 (ko) 1988-03-08 1991-02-01 침투력이 향상된 조성물
NO91910403A NO910403L (no) 1988-03-08 1991-02-01 Fremgangsmaate for fremstilling av farmasoeytisk preparat.
JP3038921A JPH04338325A (ja) 1988-03-08 1991-02-12 増強された浸透性を有する組成物
PT96779A PT96779B (pt) 1988-03-08 1991-02-15 Laminado composito de duas camadas
EP91102354A EP0499662B1 (en) 1988-03-08 1991-02-19 Compositions with enhanced penetration

Publications (1)

Publication Number Publication Date
ES2064780T3 true ES2064780T3 (es) 1995-02-01

Family

ID=32512850

Family Applications (2)

Application Number Title Priority Date Filing Date
ES89104017T Expired - Lifetime ES2056981T3 (es) 1988-03-08 1989-03-07 Composiciones dotadas de una capacidad de penetracion mejorada.
ES91102354T Expired - Lifetime ES2064780T3 (es) 1988-03-08 1991-02-19 Composiciones con penetracion mejorada.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES89104017T Expired - Lifetime ES2056981T3 (es) 1988-03-08 1989-03-07 Composiciones dotadas de una capacidad de penetracion mejorada.

Country Status (16)

Country Link
EP (2) EP0332147B1 (es)
JP (2) JP2939264B2 (es)
KR (1) KR100191456B1 (es)
AT (2) ATE90571T1 (es)
AU (2) AU611771B2 (es)
CA (1) CA2035143A1 (es)
DE (2) DE68907081T2 (es)
DK (2) DK175621B1 (es)
ES (2) ES2056981T3 (es)
FI (1) FI910455L (es)
GR (1) GR3014988T3 (es)
IE (2) IE62871B1 (es)
NO (1) NO910403L (es)
NZ (2) NZ228094A (es)
PH (1) PH26548A (es)
PT (1) PT96779B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
EP0523150A4 (en) * 1990-04-06 1993-09-29 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
DE4334919A1 (de) * 1993-10-13 1995-04-20 Liedtke Pharmed Gmbh Grenzwertig wirksame Arzneiformen mit Betablockern
US5869088A (en) * 1994-10-24 1999-02-09 Nikken Chemicals Co., Ltd Transdermal administration preparation of a 9-aminocyclopenta (b) quinoline
DE19533089C1 (de) 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
US6998138B2 (en) 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6916486B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
US6916487B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6646379B1 (en) 1998-12-25 2003-11-11 Matsushita Electric Industrial Co., Ltd. Metal vapor discharge lamp having cermet lead-in with improved luminous efficiency and flux rise time
EA004050B1 (ru) * 1998-12-11 2003-12-25 Бакулиш Мафатлал Хамар Способ изготовления состава местных бета-блокаторов улучшенного действия
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
FR2870125B1 (fr) * 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
RS52671B (sr) 2005-10-12 2013-06-28 Unimed Pharmaceuticals Llc Poboljšani gel testosterona i postupak korišćenja
JP5052558B2 (ja) * 2009-04-03 2012-10-17 ロート製薬株式会社 ゲル軟膏

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495203A (en) * 1981-10-23 1985-01-22 Societe Anonyme Dite: L'oreal Anhydrous composition, stable to oxidation, based on anthralin or one of its derivatives, in a carrier consisting of a fatty acid alkyl ester and a thickener, and its use in the treatment of skin diseases
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
CA1272445A (en) * 1985-02-25 1990-08-07 Yie W. Chien Transdermal pharmaceutical absorption dosage unit and process of pharmaceutical administration
US4816456A (en) * 1986-10-01 1989-03-28 Summers William K Administration of monoamine acridines in cholinergic neuronal deficit states
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration

Also Published As

Publication number Publication date
KR100191456B1 (ko) 1999-06-15
FI910455A0 (fi) 1991-01-30
FI910455A7 (fi) 1992-07-31
PT96779A (pt) 1992-08-31
AU611771B2 (en) 1991-06-20
KR920016085A (ko) 1992-09-24
IE64308B1 (en) 1995-07-26
NO910403L (no) 1992-08-03
IE910305A1 (en) 1992-07-29
JP2939264B2 (ja) 1999-08-25
JPH04338325A (ja) 1992-11-25
ATE90571T1 (de) 1993-07-15
EP0332147A3 (en) 1990-09-19
FI910455L (fi) 1992-07-31
ES2056981T3 (es) 1994-10-16
EP0499662A1 (en) 1992-08-26
DK109689A (da) 1989-09-09
AU7006191A (en) 1992-08-20
CA2035143A1 (en) 1992-07-30
NZ228094A (en) 1991-09-25
NZ236921A (en) 1993-08-26
AU634015B2 (en) 1993-02-11
IE890390L (en) 1989-09-08
PH26548A (en) 1992-08-19
DK109689D0 (da) 1989-03-07
DE69105480D1 (de) 1995-01-12
AU3025889A (en) 1989-09-14
PT96779B (pt) 1998-09-30
ATE114481T1 (de) 1994-12-15
EP0332147B1 (en) 1993-06-16
DE69105480T2 (de) 1995-04-06
EP0499662B1 (en) 1994-11-30
IE62871B1 (en) 1995-03-08
DK0499662T3 (da) 1995-05-15
DE68907081T2 (de) 1993-10-21
NO910403D0 (no) 1991-02-01
DK175621B1 (da) 2004-12-27
GR3014988T3 (en) 1995-05-31
DE68907081D1 (de) 1993-07-22
EP0332147A2 (en) 1989-09-13
JPH01272519A (ja) 1989-10-31

Similar Documents

Publication Publication Date Title
NO904317L (no) Laminert sammensetning for transdermal administrering av fentanyl.
ES2041238T3 (es) Matriz de difusion para la administracion de medicamento por via percutanea y dispositivo de administracion de medicamento por via percutanea que los incluye.
ES2031597T3 (es) Aparato distribuidor con un miembro dispensador para entregar un agente beneficioso.
PT86426A (pt) Dispositivo resiliente para a administracao de um medicamento por via transdermica, e dispositivos empregando esteres/eteres de acidos gordos de alcanodiois como estimuladores da absorcao percutanea
ATE4956T1 (de) Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung.
BR9206631A (pt) Sistema de maior penetração na pele para melhor administração tópica de medicamentos
ES2062392T3 (es) Medicamentos que comprenden salmeterol y fluticasona.
AR001458A1 (es) Composición farmacéutica para la administración transdérmica.
DE69414502D1 (de) Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
ES2062093T3 (es) Emplasto de varias capas.
AU634015B2 (en) Compositions with enhanced penetration
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
DK324687A (da) Transdermalt farmeceutisk praeparat
AR036838A1 (es) Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende.
KR900013993A (ko) 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도
DK34687A (da) Laegemiddel til nasal anvendelse, dets fremstilling og anvendelse
AR008229A1 (es) Dispositivos destinados a la administracion transdermica que contienen dos principios activos en compartimientos separados, su procedimiento de fabricacion y su aplicacion como medicamento.
AR245587A1 (es) Dispositivo para administrar medicamentos veterinarios.
AR024201A1 (es) Parche que contiene productos farmaceuticos, con tres capas funcionales
KR970058734A (ko) 신규 경피 투여 장치
ES2063020T3 (es) Formulacion medicamentosa de absorcion transdermica.
KR890001599A (ko) 불연속 패턴 접착층을 갖는 피부 및 경피용 패치
KR890007747A (ko) 약쑥과 한방 생약성분이 함유된 피부미용 스킨

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 499662

Country of ref document: ES